The influence of diabetes on microalbunimuria

Younes S and Shbani A

Published on: 2024-03-13

Abstract

Diabetes is currently the leading cause of end-stage renal disease (ESRD) in both the United States and Europe. The prevalence of type 2 diabetes is increasing, leading to a longer life expectancy for individuals with diabetes. Consequently, there has been a rise in the number of patients with diabetic ESRD seeking treatment in ESRD programs that previously denied them. This trend has contributed to the overall increase in ESRD cases. Nephropathy, a condition affecting 20–30% of individuals with type 1 or type 2 diabetes, is a significant risk factor for developing end-stage renal disease. However, it is important to note that only a smaller proportion of individuals with type 2 diabetes progress to end-stage renal disease. Nonetheless, due to the higher prevalence of type 2 diabetes, these patients constitute more than half of all diabetic patients initiating dialysis. Recent studies have demonstrated the effectiveness of various therapies in managing diabetic ESRD.